ecMetAP-IN-1

CAS No. 7471-12-7

ecMetAP-IN-1( —— )

Catalog No. M35307 CAS No. 7471-12-7

ecMetAP-IN-1 can be used as a QSAR model to study methionine aminopeptidase inhibitor as an anticancer agent using multiple linear regression.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 39 Get Quote
10MG 54 Get Quote
25MG 82 Get Quote
50MG 121 Get Quote
100MG 172 Get Quote
200MG 255 Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    ecMetAP-IN-1
  • Note
    Research use only, not for human use.
  • Brief Description
    ecMetAP-IN-1 can be used as a QSAR model to study methionine aminopeptidase inhibitor as an anticancer agent using multiple linear regression.
  • Description
    ecMetAP-IN-1 (compound 17) is a potent ecMetAP inhibitor with an IC50 value of 2.086 μM.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Others
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    7471-12-7
  • Formula Weight
    209.25
  • Molecular Formula
    C13H11N3
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    CC=1C=C2N=C(NC2=CC1)C3=CC=CC=N3
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Schiffmann R, et al. Metal-mediated inhibition of Escherichia coli methionine aminopeptidase: structure-activity relationships and development of a novel scoring function for metal-ligand interactions. J Med Chem. 2006 Jan 26;49(2):511-22.?
molnova catalog
related products
  • Cdk4/6 Inhibitor IV

    Cdk4/6 inhibitor IV is a cell-permeable triaminopyrimidine that reversibly blocks Cdk4/cyclin D1 and Cdk6/cyclin D1 activity with IC50 values of 1.5 and 5.6 μM, respectively.

  • Reynoutrin

    Reynoutrin with antioxidant and radical-scavenging activity.

  • BR-1

    BR-1 is a phosphatase of regenerating liver 3 (PRL-3) inhibitor which blocks the migration and invasion of metastatic cancer cells.